Variability of onset times within and among relaxant regimens
- PMID: 1347222
- DOI: 10.1016/0952-8180(92)90116-i
Variability of onset times within and among relaxant regimens
Abstract
Study objective: To evaluate the consistency of times to 95% twitch height depression (T95%) in groups of patients receiving identical induction and relaxant regimens.
Design: Prospective, noncontrolled, blinded study.
Setting: Ambulatory surgical unit at a university medical center.
Patients: Seventy-five ASA physical status I and II patients undergoing general endotracheal anesthesia.
Interventions: Patients received succinylcholine 1.5 mg/kg or a nondepolarizing regimen with doses ranging from approximately 1.5 to 6 times the ED95, with or without a priming dose.
Measurements and main results: For each of the eight relaxant regimens used in five or more patients, the intraregimen variability of T95% (at the adductor pollicis muscle upon ulnar stimulation at 0.1 Hz) was expressed as SD and range, and the individual data points were displayed. There was wide intraregimen variability. For each regimen, the slowest T95% was at least 73% longer than the fastest T95%. For the 16 patients receiving a priming dose plus an intubating dose 5 or more times the ED95, the median T95% was 95 seconds; however, T95% was beyond 120 seconds in 5 of the 16 cases.
Conclusions: The wide variability in onset times among subjects receiving the same regimen indicates that monitoring of neuromuscular response, preferably to a relatively slow rate of neurostimulation, is essential if one elects to use moderate to high doses of atracurium and/or vecuronium for rapid-sequence induction in a patient in whom movement or coughing is unacceptable. Since onset times were not symmetrical about the mean, the magnitude and frequency of unacceptable onset times would not be fully appreciated unless the individual data points were displayed. Such information may be critical when reporting the suitability of a neuromuscular blocking drug for rapid intubation.
Similar articles
-
Rocuronium priming of atracurium-induced neuromuscular blockade: the use of short priming intervals.J Clin Anesth. 1996 Aug;8(5):376-81. doi: 10.1016/0952-8180(96)00078-5. J Clin Anesth. 1996. PMID: 8832448 Clinical Trial.
-
The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.Anesth Analg. 1997 Dec;85(6):1278-83. doi: 10.1097/00000539-199712000-00018. Anesth Analg. 1997. PMID: 9390594 Clinical Trial.
-
The effect of d-tubocurarine priming on an ED95 dose of vecuronium bromide.J Clin Anesth. 1994 Mar-Apr;6(2):106-9. doi: 10.1016/0952-8180(94)90005-1. J Clin Anesth. 1994. PMID: 7911306 Clinical Trial.
-
Newer neuromuscular blocking agents: how do they compare with established agents?Drugs. 2001;61(7):919-42. doi: 10.2165/00003495-200161070-00003. Drugs. 2001. PMID: 11434449 Review.
-
The optimal dose of succinylcholine for rapid sequence induction: a systematic review and meta-analysis of randomized trials.BMC Anesthesiol. 2020 Mar 2;20(1):54. doi: 10.1186/s12871-020-00968-1. BMC Anesthesiol. 2020. PMID: 32122305 Free PMC article.
Cited by
-
Monitoring of neuromuscular function in the clinical setting.Yale J Biol Med. 1993 Sep-Oct;66(5):473-89. Yale J Biol Med. 1993. PMID: 7825349 Free PMC article. Review.
-
Laparoscopic partial nephrectomy in a patient on simvastatin : Delayed recovery from neuromuscular blockade.Anaesthesist. 2017 Jun;66(6):422-425. doi: 10.1007/s00101-017-0284-6. Epub 2017 Mar 6. Anaesthesist. 2017. PMID: 28265685 English.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources